PPARgamma agonists do not directly enhance basal or insulin-stimulated Na(+) transport via the epithelial Na(+) channel.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 16170524)

Published in Pflugers Arch on September 17, 2005

Authors

Charity Nofziger1, Lihong Chen, Michael Anne Shane, Chari D Smith, Kathleen K Brown, Bonnie L Blazer-Yost

Author Affiliations

1: Department of Biology, Indiana University Purdue University at Indianapolis, Indianapolis, IN 46202, USA.

Articles citing this

Thiazolidinedione-induced fluid retention is independent of collecting duct alphaENaC activity. J Am Soc Nephrol (2009) 1.44

Renal and vascular mechanisms of thiazolidinedione-induced fluid retention. PPAR Res (2008) 0.92

Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney. Am J Physiol Renal Physiol (2011) 0.91

Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone. Pflugers Arch (2008) 0.91

Effects of chronic PPAR-agonist treatment on cardiac structure and function, blood pressure, and kidney in healthy sprague-dawley rats. PPAR Res (2009) 0.90

Protective effects of PPARγ agonist in acute nephrotic syndrome. Nephrol Dial Transplant (2011) 0.88

BMP7 and SHH regulate Pax2 in mouse retinal astrocytes by relieving TLX repression. Dev Biol (2009) 0.87

Thiazolidinedione-induced fluid retention: recent insights into the molecular mechanisms. PPAR Res (2013) 0.83

D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression. J Hypertens (2009) 0.83

Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention. PPAR Res (2015) 0.81

Effects of peroxisome proliferator-activated receptor gamma agonists on Na+ transport and activity of the kinase SGK1 in epithelial cells from lung and kidney. Br J Pharmacol (2010) 0.81

PPARgamma Agonists: Blood Pressure and Edema. PPAR Res (2009) 0.80

Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors. PPAR Res (2010) 0.80

PPARγ agonist-induced fluid retention depends on αENaC expression in connecting tubules. Nephron (2014) 0.78

Role of Rho GDP dissociation inhibitor α in control of epithelial sodium channel (ENaC)-mediated sodium reabsorption. J Biol Chem (2014) 0.76

Role of renal proximal tubule transport in thiazolidinedione-induced volume expansion. World J Nephrol (2012) 0.76

Species differences in regulation of renal proximal tubule transport by certain molecules. World J Nephrol (2015) 0.75

Insulin-induced electrophysiology changes in human pleura are mediated via its receptor. Exp Diabetes Res (2010) 0.75

Articles cited by this

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem (1995) 13.34

Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell (1994) 5.29

Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol (1994) 5.13

Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet (1996) 3.58

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Circulation (2003) 3.22

Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem (2001) 3.17

The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest (1975) 2.97

Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line. J Am Soc Nephrol (1999) 2.88

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney Int (2001) 2.08

Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem (1998) 2.00

Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab (2001) 1.93

The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia (1981) 1.68

The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J Biol Chem (1995) 1.62

Nonhypoglycemic effects of thiazolidinediones. Ann Intern Med (2001) 1.61

Characterization of a mouse cortical collecting duct cell line. Kidney Int (1991) 1.60

Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. Am J Physiol (1997) 1.46

Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel alpha subunit in A6 renal cells. J Am Soc Nephrol (1997) 1.39

Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol (2003) 1.33

Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. J Clin Invest (1995) 1.29

Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats. J Pharmacol Exp Ther (2003) 1.28

Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney. Am J Physiol (1999) 1.22

PPARgamma activation enhances cell surface ENaCalpha via up-regulation of SGK1 in human collecting duct cells. FASEB J (2003) 1.13

Insulin-stimulated trafficking of ENaC in renal cells requires PI 3-kinase activity. Am J Physiol Cell Physiol (2003) 1.02

Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature. Am J Physiol Renal Physiol (2001) 1.01

Regulation of sodium transport in M-1 cells. Am J Physiol (1998) 0.99

sgk: an essential convergence point for peptide and steroid hormone regulation of ENaC-mediated Na+ transport. Am J Physiol Cell Physiol (2002) 0.95

Insulin resistance: a chicken that has come to roost. Ann N Y Acad Sci (1999) 0.92

Regional hemodynamic effects of the N-(2-benzoylphenyl)-L-tyrosine peroxisome proliferator-activated receptor-gamma ligand, GI 262570 [(S)-2-(2-benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic acid], in conscious rats. J Pharmacol Exp Ther (2004) 0.88

Insulin resistance in young salt-sensitive normotensive subjects. Hypertension (1993) 0.84

Long-term fructose feeding impairs vascular relaxation in rat mesenteric arteries. Am J Hypertens (2001) 0.83

Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats. Hypertension (1998) 0.82

Peroxisome proliferator-activated receptor-gamma in the renal mesangium. Curr Opin Nephrol Hypertens (2002) 0.78

Effect of pioglitazone on vascular reactivity in vivo and in vitro. Am J Physiol (1996) 0.76

Insulin increases sodium (Na+) channel density in A6 epithelia: implications for expression of hypertension. Biol Res Nurs (1999) 0.75

Articles by these authors

Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res (2005) 3.56

Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest (2004) 3.23

Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes (2005) 3.20

VFDB 2008 release: an enhanced web-based resource for comparative pathogenomics. Nucleic Acids Res (2007) 3.07

Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Invest (2003) 2.87

Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol (2006) 2.85

MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J (2005) 1.85

MDMX regulation of p53 response to ribosomal stress. EMBO J (2006) 1.77

Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. EMBO J (2006) 1.67

Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury. Kidney Int (2011) 1.59

ATM activates p53 by regulating MDM2 oligomerization and E3 processivity. EMBO J (2009) 1.56

Revisiting the molecular evolutionary history of Shigella spp. J Mol Evol (2006) 1.54

Complete genome sequence of Shigella flexneri 5b and comparison with Shigella flexneri 2a. BMC Genomics (2006) 1.54

DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms. Mol Cell Biol (2002) 1.53

Mechanism and management of AKT inhibitor-induced hyperglycemia. Clin Cancer Res (2009) 1.53

Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J Clin Invest (2007) 1.45

PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells. Biochem Biophys Res Commun (2006) 1.42

SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem (2009) 1.33

ShiBASE: an integrated database for comparative genomics of Shigella. Nucleic Acids Res (2006) 1.31

Inhibition of SUV39H1 methyltransferase activity by DBC1. J Biol Chem (2009) 1.31

Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin Appl (2008) 1.22

GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats. J Pharmacol Exp Ther (2004) 1.16

Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial. Urology (2012) 1.14

Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. Am J Physiol Endocrinol Metab (2005) 1.14

Rescue of mutant p53 transcription function by ellipticine. Oncogene (2003) 1.14

Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonists. J Med Chem (2009) 1.13

Inhibitor binding in the human renal low- and high-affinity Na+/glucose cotransporters. J Pharmacol Exp Ther (2007) 1.13

Developmental exposure of rats to chlorpyrifos elicits sex-selective hyperlipidemia and hyperinsulinemia in adulthood. Environ Health Perspect (2005) 1.12

The use of global transcriptional analysis to reveal the biological and cellular events involved in distinct development phases of Trichophyton rubrum conidial germination. BMC Genomics (2007) 1.11

Overexpression of a wheat aquaporin gene, TaAQP8, enhances salt stress tolerance in transgenic tobacco. Plant Cell Physiol (2012) 1.11

Positional cloning of "Lisch-Like", a candidate modifier of susceptibility to type 2 diabetes in mice. PLoS Genet (2008) 1.10

Exposure of neonatal rats to parathion elicits sex-selective reprogramming of metabolism and alters the response to a high-fat diet in adulthood. Environ Health Perspect (2008) 1.09

TaASR1, a transcription factor gene in wheat, confers drought stress tolerance in transgenic tobacco. Plant Cell Environ (2013) 1.09

Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus. Clin Endocrinol (Oxf) (2012) 1.07

Draft genome of a Brazilian avian-pathogenic Escherichia coli strain and in silico characterization of virulence-related genes. J Bacteriol (2012) 1.07

Shear stress induces synthetic-to-contractile phenotypic modulation in smooth muscle cells via peroxisome proliferator-activated receptor alpha/delta activations by prostacyclin released by sheared endothelial cells. Circ Res (2009) 1.07

Overexpression of the wheat aquaporin gene, TaAQP7, enhances drought tolerance in transgenic tobacco. PLoS One (2012) 1.06

The complete sequence and analysis of the large virulence plasmid pSS of Shigella sonnei. Plasmid (2005) 1.03

Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum. Antimicrob Agents Chemother (2006) 1.02

Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury. Circulation (2011) 1.01

Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats. BMC Pharmacol (2004) 1.00

Regulation of MDM2 E3 ligase activity by phosphorylation after DNA damage. Mol Cell Biol (2011) 1.00

Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene. Bioorg Med Chem Lett (2010) 0.99

Inhibition of p53 DNA binding function by the MDM2 protein acidic domain. J Biol Chem (2011) 0.99

Complete genome sequence of Haemophilus parasuis SH0165. J Bacteriol (2008) 0.98

Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease. Exp Biol Med (Maywood) (2008) 0.97

Dynamic changes in matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 levels during wound healing in diabetic rats. J Am Podiatr Med Assoc (2009) 0.96

Complete genome sequence of the extremophilic Bacillus cereus strain Q1 with industrial applications. J Bacteriol (2008) 0.96

Quantitative studies on structure-ORAC relationships of anthocyanins from eggplant and radish using 3D-QSAR. Food Chem (2013) 0.95

sgk: an essential convergence point for peptide and steroid hormone regulation of ENaC-mediated Na+ transport. Am J Physiol Cell Physiol (2002) 0.95

Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule. Am J Physiol Renal Physiol (2005) 0.94

Hormonal regulation of the epithelial Na+ channel: from amphibians to mammals. Gen Comp Endocrinol (2006) 0.94

PPARgamma agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line. Am J Physiol Renal Physiol (2009) 0.94

Casein kinase 1α regulates an MDMX intramolecular interaction to stimulate p53 binding. Mol Cell Biol (2012) 0.94

TaCIPK29, a CBL-interacting protein kinase gene from wheat, confers salt stress tolerance in transgenic tobacco. PLoS One (2013) 0.93

Effectiveness of the PPARγ agonist, GW570, in liver fibrosis. Inflamm Res (2010) 0.92

Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone. Pflugers Arch (2008) 0.91

Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells. Oncol Rep (2012) 0.90

Ectopic expression of wheat TaCIPK14, encoding a calcineurin B-like protein-interacting protein kinase, confers salinity and cold tolerance in tobacco. Physiol Plant (2013) 0.89

TrED: the Trichophyton rubrum Expression Database. BMC Genomics (2007) 0.89

Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064. Bioorg Med Chem Lett (2008) 0.89

Regulation of SirT1-nucleomethylin binding by rRNA coordinates ribosome biogenesis with nutrient availability. Mol Cell Biol (2013) 0.89

Effects of a PPARgamma agonist, GI262570, on renal filtration fraction and nitric oxide level in conscious rats. J Cardiovasc Pharmacol (2003) 0.89

Causative species and serotypes of shigellosis in mainland China: systematic review and meta-analysis. PLoS One (2012) 0.89

Regional hemodynamic effects of the N-(2-benzoylphenyl)-L-tyrosine peroxisome proliferator-activated receptor-gamma ligand, GI 262570 [(S)-2-(2-benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic acid], in conscious rats. J Pharmacol Exp Ther (2004) 0.88

Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin. Protein Expr Purif (2006) 0.88

Newly identified cytoskeletal components are associated with dynamic changes of podocyte foot processes. Nephrol Dial Transplant (2009) 0.88

Peroxisome proliferator-activated receptors and renal diseases. Front Biosci (Landmark Ed) (2009) 0.88

Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats. Am J Physiol Renal Physiol (2008) 0.87

Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94. J Lipid Res (2002) 0.87

Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet aggregation. Thromb Res (2010) 0.87

Functional effects of nanoparticle exposure on Calu-3 airway epithelial cells. Cell Physiol Biochem (2012) 0.86

PPARgamma agonists, modulation of ion transporters, and fluid retention. J Am Soc Nephrol (2009) 0.86

Evaluation of the clinical features of HCC following hepatectomy for different stages of HCC. Hepatogastroenterology (2012) 0.85

Transcutaneous oxygen pressure measurement in diabetic foot ulcers: mean values and cut-point for wound healing. J Wound Ostomy Continence Nurs (2013) 0.84

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma. Cancer Sci (2014) 0.84

Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats. Biochem Biophys Res Commun (2006) 0.84

Expression of mouse membrane-associated prostaglandin E2 synthase-2 (mPGES-2) along the urogenital tract. Biochim Biophys Acta (2006) 0.84

Vasopressin regulates the phosphorylation state of AMP-activated protein kinase (AMPK) in MDCK-C7 cells. Cell Physiol Biochem (2008) 0.84

Identification and characterization of simple sequence repeats in the genomes of Shigella species. Gene (2003) 0.83

Expression of the unconventional myosin Myo1c alters sodium transport in M1 collecting duct cells. Am J Physiol Cell Physiol (2005) 0.83

FXR agonist activity of conformationally constrained analogs of GW 4064. Bioorg Med Chem Lett (2009) 0.83

Effects of different proportion of carbohydrate in breakfast on postprandial glucose excursion in normal glucose tolerance and impaired glucose regulation subjects. Diabetes Technol Ther (2013) 0.83

Endogenous peroxisome proliferator-activated receptor-gamma augments fatty acid uptake in oxidative muscle. Endocrinology (2008) 0.83

Angiotensin II regulates collagen metabolism through modulating tissue inhibitor of metalloproteinase-1 in diabetic skin tissues. Diab Vasc Dis Res (2013) 0.82

The biomarker enriched proteome of autosomal dominant polycystic kidney disease cyst fluid. Proteomics Clin Appl (2009) 0.82

MH1 domain of SMAD4 binds N-terminal residues of the homeodomain of Hoxc9. Biochim Biophys Acta (2008) 0.82

Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes. Am J Physiol Endocrinol Metab (2010) 0.81

PPARs and Female Reproduction: Evidence from Genetically Manipulated Mice. PPAR Res (2008) 0.81

The NAD+ synthesis enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT1) regulates ribosomal RNA transcription. J Biol Chem (2013) 0.81

Protein composition of liver cyst fluid from the BALB/c-cpk/+ mouse model of autosomal recessive polycystic kidney disease. Proteomics (2009) 0.80

Protein expression profiles of intestinal epithelial co-cultures: effect of functionalised carbon nanotube exposure. Int J Biomed Nanosci Nanotechnol (2013) 0.80

[Association of the cocaine and amphetamine-regulated transcript gene with type 2 diabetes mellitus]. Zhonghua Nei Ke Za Zhi (2002) 0.80

Conformationally constrained farnesoid X receptor (FXR) agonists: alternative replacements of the stilbene. Bioorg Med Chem Lett (2011) 0.80

A human polymorphism affects NEDD4L subcellular targeting by leading to two isoforms that contain or lack a C2 domain. BMC Cell Biol (2009) 0.80